MONTLIP-M
Controls allergy, controls airway infammation
Leukotrienes are a group of naturally occurring chemicals in the body that promote inflammation in asthma and seasonal allergic rhinitis and in other diseases in which inflammation is important (such as allergy). They are formed by cells, released, and then bound to other cells that cause inflammation. It is the binding to other cells that stimulates the cells to cause inflammation. Montelukast works in a manner blocking the binding of some leukotrienes to the cells that cause inflammation.
INDICATIONS
• Perennial/seasonal respiratory allergy
• Allergic rhinitis
• Allergic asthma
• Bronchospasm (narrowing of airways)
MONTLIP-DM
It is long-acting antihistamine. It is used to treat the symptoms caused by histamine. Histamine is a chemical that is responsible for many of the signs and symptoms of allergic reactions. Histamine is released from histamine-storing cells (mast cells) and then attaches to other cells that have receptors for histamine. The attachment of the histamine to the receptors causes the cells to be "activated," releasing other chemicals which produce the effects that we associate with allergy. It blocks one type of receptor for histamine (the H1 receptor) and thus prevents activation of H1 receptor-containing cells by histamine. Desloratadine does not readily enter the brain from the blood and, therefore, causes less drowsiness (sedation).
Indications:
• It is used for the treatment of allergies and chronic urticaria (hives) in adults and children 6 months of age or older.
• Swelling of the lining of the nose, sneezing, and itchy eyes.
• It is also used for the treatment of asthma, seasonal allergic rhinitis, and prevention of exercise induced bronchospasm (narrowing of airways).
Mr.K Ragunathan, (48)
Chairman
The pharmaceutical industry needs a high level of consistency in terms of quality of drugs and medicines they manufacture and continue to strive for honouring commitments to clients. Globally there have been concerted efforts to monitor quality and regulate pharma operations for quality health care being extended to the target population.
Towards this end, we at Lipak India are constantly evolving to newer heights by placing our focus on Products, Processes and People as central themes to guide our business philosophy. With Innovation being a value driver, our strategic planning started in early 2011 with an ideation session analysing Lipak India's current strengths, weaknesses, opportunities and threats. We will be continuing our dialogue on strategic planning throughout the next several months, looking at financial health, research and development focus, management structure, operational efficiency, risk management, stakeholder communication, shareholder wealth creation and corporate social responsibility.
By the end of this process, we will be credited with a clear road map that will help us navigate smoothly through the challenges ahead.
Over the last decade many pharma organisations across India have started adopting various excellence initiatives. These initiatives are supposed to aid organisations in creating value and help face the challenging business needs. Let me hasten to add that Lipak India has seized this opportunity by adopting certain companywide initiatives such as management restructuring, venturing into newer business portfolios, enterprise resource planning, setting up HR governing council and adoption of operational excellence cell apart from culling out task force teams in quality and R&D with a view to provide the best pharma solutions to our esteemed clients
Lipak India stands today as one of the few distinguished vertically integrated pharmaceutical companies with a robust product portfolio produced out of our own approved manufacturing facilities, both in the areas of API and Formulations, with enviable longstanding business partnerships.
Over the years, we have grown from strength to strength and our global team of more than 9,500 scientists, technicians, sales, marketing, financial, manufacturing, quality, administrative and other business professional’s work together to achieve our global mission - "Committed to healthier life”.
We are sure that with the continued support and patronage of all our stakeholders, Lipak India will continue to enjoy the saga of business excellence in the healthcare sector in the coming periods, cutting across geographical boundaries.
We are Lipak India Ltd. “A global pharmaceutical company with great commitment to a healthier life".
